Back to search

Article

A potential alternative systemic treatment option for epithelioid sarcoma

2022-12-22

Abstract excerpt

<h4>Background: </h4> Epithelioid sarcoma is a rare soft tissue sarcoma characterized by SMARCB1/INI1 deficiency. Much attention has been paid to the selective EZH2 inhibitor tazemetostat, where other systemic treatments are generally ignored. To explore alternative treatment options, we studied the effects of irinotecan-based chemotherapy in a series of epithelioid sarcoma patients. <h4>Methods: </h4> We retrosp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
87d32a0b-7703-5f00-aa35-22d299217f3c
DOI
10.21203/rs.3.rs-2341639/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A potential alternative systemic treatment option for epithelioid sarcomaDOI 10.21203/rs.3.rs-2341639/v1
Histone deacetylase activity limits the response to EZH2 inhibition-based therapy in epithelioid sarcoma and is targetable by epigenetic combinationSemantic proximity
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.Semantic proximity
Histone deacetylase activity limits the response to EZH2 inhibition-based therapy in epithelioid sarcoma and is targetable by epigenetic combinationSemantic proximity
Uzatresgene autoleucel autologous T-cell monotherapy for advanced solid tumors: SURPASS, a phase 1, open-label trialSemantic proximity
Targeted treatment of soft-tissue sarcomaSemantic proximity
The UK Divide: Does having a Pembrolizumab-Chemotherapy option in head and neck cancer matter? Real-world experience of first-line palliative pembrolizumab monotherapy and pembrolizumab-chemotherapy combination in ScotlandSemantic proximity
Regorafenib in Bone Sarcoma: A Systematic Review and Meta-Analysis of Its Effectiveness and Safety in Cancer TreatmentSemantic proximity
Systemic Options for Malignant Peripheral Nerve Sheath Tumors.Semantic proximity
Evaluating Treatment Efficacy in Intimal Sarcoma: A Case Cohort AnalysisSemantic proximity
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II StudySemantic proximity
Systemic Therapy for Chondrosarcoma.Semantic proximity
Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.Semantic proximity
Select a neighboring publication to make it the new centre.